{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Zhang X"],"funding":["The Key Scientific Research Project of Colleges and Universities in Henan Province of China","Renshu Fund Project of Hunan Provincial People’s Hospital","Renshu Fund Project of Hunan Provincial People's Hospital","National Science and Technology Major Project of China under Grant","The Training Program of Henan Provincial Higher Vocational School Young Backbone Teachers","The Science and Technology Project in Henan Province of China","The Joint Construction Project of Henan Medical Science and Technology Research Plan in Henan Province of China"],"pagination":["393"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9733014"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["22(1)"],"pubmed_abstract":["Background
The dysregulation of CD5L has been reported in hepatocellular carcinoma (HCC). However, its functions in HCC were controversial. In this study, we aimed to identify CD5L-associated pathways and markers and explore their values in HCC diagnosis, prognosis and treatment.Methods
HCC datasets with gene expression profiles and clinical data in TCGA and ICGC were downloaded. The immune/stroma cell infiltrations were estimated with xCell. CD5L-associated pathways and CD5L-associated genes (CD5L-AGs) were identified with gene expression comparisons and gene set enrichment analysis (GSEA). Cox regression, Kaplan-Meier survival analysis, and least absolute shrinkage and selection operator (LASSO) regression analysis were performed. The correlations of the key genes with im"],"journal":["Cancer cell international"],"pubmed_title":["CD5L-associated gene analyses highlight the dysregulations, prognostic effects, immune associations, and drug-sensitivity predicative potentials of LCAT and CDC20 in hepatocellular carcinoma."],"pmcid":["PMC9733014"],"funding_grant_id":["LHGJ20190717","20B320007","222102310408","2020-20","RS201803","2018ZX10302205"],"pubmed_authors":["Liu X","Dai L","Zhang J","Zhang X","Zhu K","Sun T","Fan S","Li N"],"additional_accession":[]},"is_claimable":false,"name":"CD5L-associated gene analyses highlight the dysregulations, prognostic effects, immune associations, and drug-sensitivity predicative potentials of LCAT and CDC20 in hepatocellular carcinoma.","description":"Background
The dysregulation of CD5L has been reported in hepatocellular carcinoma (HCC). However, its functions in HCC were controversial. In this study, we aimed to identify CD5L-associated pathways and markers and explore their values in HCC diagnosis, prognosis and treatment.Methods
HCC datasets with gene expression profiles and clinical data in TCGA and ICGC were downloaded. The immune/stroma cell infiltrations were estimated with xCell. CD5L-associated pathways and CD5L-associated genes (CD5L-AGs) were identified with gene expression comparisons and gene set enrichment analysis (GSEA). Cox regression, Kaplan-Meier survival analysis, and least absolute shrinkage and selection operator (LASSO) regression analysis were performed. The correlations of the key genes with im","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Dec","modification":"2026-05-29T18:48:09.195Z","creation":"2024-11-13T21:50:38.903Z"},"accession":"S-EPMC9733014","cross_references":{"pubmed":["36494696"],"doi":["10.1186/s12935-022-02820-7"]}}